Attached files
| file | filename |
|---|---|
| EX-4.1 - EX-4.1 - ARGOS THERAPEUTICS INC | d621316dex41.htm |
| EX-10.17 - EX-10.17 - ARGOS THERAPEUTICS INC | d621316dex1017.htm |
| EX-10.20 - EX-10.20 - ARGOS THERAPEUTICS INC | d621316dex1020.htm |
| EX-10.21 - EX-10.21 - ARGOS THERAPEUTICS INC | d621316dex1021.htm |
| EX-10.5 - EX-10.5 - ARGOS THERAPEUTICS INC | d621316dex105.htm |
| EX-10.7 - EX-10.7 - ARGOS THERAPEUTICS INC | d621316dex107.htm |
| EX-10.6 - EX-10.6 - ARGOS THERAPEUTICS INC | d621316dex106.htm |
| EX-1.1 - EX-1.1 - ARGOS THERAPEUTICS INC | d621316dex11.htm |
| EX-5.1 - EX-5.1 - ARGOS THERAPEUTICS INC | d621316dex51.htm |
| EX-23.1 - EX-23.1 - ARGOS THERAPEUTICS INC | d621316dex231.htm |
| S-1/A - AMENDMENT NO. 1 TO FORM S-1 - ARGOS THERAPEUTICS INC | d621316ds1a.htm |
EXHIBIT 99.1
CONSENT
I hereby consent to being named in the Registration Statement on Form S-1 of Argos Therapeutics, Inc. (the “Company”) and all amendments thereto (File No. 333-193137) (the “Registration Statement”) as a person who will become a director of the Company upon the consummation of the transactions contemplated in the Registration Statement.
| /s/ Alexey Vinogradov |
| Name: Alexey Vinogradov, Ph.D. |
| January 21, 2014 |